The week’s remaining deals came from small Asian issuers, led by Chinese supply chain management firm Majestic Ideal Holdings ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S. initial public ...

The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

IPO fundraising in the U.K. market fell to at least a 30-year low in the first half of this year, according to data from Dealogic.

The success of offerings like Circle, CoreWeave, and eToro Group — which all raised more than $600 million on their IPOs — is pushing leadership at private firms operating at that scale to ...

IPO market begins to show signs of life as ASIC cuts red tape GemLife hits ASX with $1.6b luxury retirement splash GLF tops Virgin with biggest Aussie float of 2025 For the last couple of years, the ...